Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Centogene AG - the Rare Disease Company Germany | 243 | 238 |
|
Centogene AG - the Rare Disease Company Germany | 316 | 314 |
|
HSD17B3 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Invitae Disorders of Sex Development Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 88 | 53 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae Comprehensive Carrier Screen Labcorp Genetics (formerly Invitae) LabCorp United States | 886 | 547 |
|
PreventionGenetics, part of Exact Sciences United States | 156 | 73 |
|
PreventionGenetics, part of Exact Sciences United States | 128 | 85 |
|
Differences of Sex Development (DSD) Panel PreventionGenetics, part of Exact Sciences United States | 149 | 158 |
|
Differences of Sex Development (DSD) and Infertility Panel PreventionGenetics, part of Exact Sciences United States | 223 | 238 |
|
PreventionGenetics, part of Exact Sciences United States | 128 | 139 |
|
PreventionGenetics, part of Exact Sciences United States | 96 | 105 |
|
qGenEx Sex development disorders Quantitative Genomic Medicine Laboratories, SL Spain | 45 | 48 |
|
X-chromosome High Resolution microarray analysis Pittsburgh Cytogenetics Laboratory University of Pittsburgh Medical Center United States | 240 | 171 |
|
46,XY Difference of Sex Development (DSD) via the HSD17B3 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Genital Abnormalities / Sex Development Disorders Panel Genologica Medica Spain | 95 | 49 |
|
Fulgent Genetics United States | 79 | 45 |
|
17-Beta Hydroxysteroid Dehydrogenase 3 Deficiency (HSD17B3 Single Gene Test) Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 92 | 56 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.